相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Updated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform?
Roger L. Nation et al.
CLINICAL INFECTIOUS DISEASES (2016)
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
Andre C. Kalil et al.
CLINICAL INFECTIOUS DISEASES (2016)
Global survey on nebulization of antimicrobial agents in mechanically ventilated patients: a call for international guidelines
C. Sole-Lleonart et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Agents of Last Resort Polymyxin Resistance
Keith S. Kaye et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2016)
Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study
Yi-Yun Liu et al.
LANCET INFECTIOUS DISEASES (2016)
Intratracheal Administration of Antimicrobial Agents in Mechanically Ventilated Adults: An International Survey on Delivery Practices and Safety
Candela Sole-Lleonart et al.
RESPIRATORY CARE (2016)
The use of inhaled antibiotic therapy in the treatment of ventilator-associated pneumonia and tracheobronchitis: a systematic review
Christopher J. Russell et al.
BMC PULMONARY MEDICINE (2016)
Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial
Sami Abdellatif et al.
ANNALS OF INTENSIVE CARE (2016)
Characteristics of an ideal nebulized antibiotic for the treatment of pneumonia in the intubated patient
Matteo Bassetti et al.
ANNALS OF INTENSIVE CARE (2016)
Inhaled antimicrobial therapy - Barriers to effective treatment
Jeffry Weers
ADVANCED DRUG DELIVERY REVIEWS (2015)
The Role of Aerosolized Colistin in the Treatment of Ventilator-Associated Pneumonia: A Systematic Review and Metaanalysis
Antonis Valachis et al.
CRITICAL CARE MEDICINE (2015)
Ventilator-associated infection
Lucy B. Palmer
CURRENT OPINION IN PULMONARY MEDICINE (2015)
Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria
Matteo Bassetti et al.
INTENSIVE CARE MEDICINE (2015)
Intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of pneumonia caused by multidrug-resistant pathogens: a systematic review and meta-analysis
Dong Liu et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Cystic fibrosis microbiology: Advances in antimicrobial therapy
Valerie Waters et al.
JOURNAL OF CYSTIC FIBROSIS (2015)
Pulmonary Delivery of Vancomycin Dry Powder Aerosol to Intubated Rabbits
Bradley P. Sullivan et al.
MOLECULAR PHARMACEUTICS (2015)
Nebulized antibiotics for ventilator-associated pneumonia: a systematic review and meta-analysis
Fernando G. Zampieri et al.
CRITICAL CARE (2015)
Reduction of Bacterial Resistance with Inhaled Antibiotics in the Intensive Care Unit
Lucy B. Palmer et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Comparison of Intrapulmonary and Systemic Pharmacokinetics of Colistin Methanesulfonate (CMS) and Colistin after Aerosol Delivery and Intravenous Administration of CMS in Critically Ill Patients
Matthieu Boisson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Pulmonary and Systemic Pharmacokinetics of Inhaled and Intravenous Colistin Methanesulfonate in Cystic Fibrosis Patients: Targeting Advantage of Inhalational Administration
Shalini W. S. Yapa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Potentiation Effects of Amikacin and Fosfomycin against Selected Amikacin-Nonsusceptible Gram-Negative Respiratory Tract Pathogens
A. Bruce Montgomery et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Amikacin-Fosfomycin at a Five-to-Two Ratio: Characterization of Mutation Rates in Microbial Strains Causing Ventilator-Associated Pneumonia and Interactions with Commonly Used Antibiotics
A. Bruce Montgomery et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Consistent Global Approach on Reporting of Colistin Doses to Promote Safe and Effective Use
Roger L. Nation et al.
CLINICAL INFECTIOUS DISEASES (2014)
A Phase 3 Randomized Double-Blind Comparison of Ceftobiprole Medocaril Versus Ceftazidime Plus Linezolid for the Treatment of Hospital-Acquired Pneumonia
Samir S. Awad et al.
CLINICAL INFECTIOUS DISEASES (2014)
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current β-Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
Jason A. Roberts et al.
CLINICAL INFECTIOUS DISEASES (2014)
A Randomized Double-Blind Placebo-Controlled Dose-Escalation Phase 1 Study of Aerosolized Amikacin and Fosfomycin Delivered via the PARI Investigational eFlow® Inline Nebulizer System in Mechanically Ventilated Patients
A. Bruce Montgomery et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2014)
National Trends in Patient Safety for Four Common Conditions, 2005-2011
Yun Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Ventilator-Integrated Jet Nebulization Systems: Tidal Volume Control and Efficiency of Synchronization
Stephan Ehrmann et al.
RESPIRATORY CARE (2014)
Ventilatory Strategies in Obstructive Lung Disease
Francisco Jose Parrilla et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Higher clinical success in patients with ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus treated with linezolid compared with vancomycin: results from the IMPACT-HAP study
Paula Peyrani et al.
CRITICAL CARE (2014)
A Randomized Double-Blind Placebo-Controlled Dose-Escalation Phase 1 Study of Aerosolized Amikacin and Fosfomycin Delivered via the PARI Investigational eFlow((R)) Inline Nebulizer System in Mechanically Ventilated Patients
Paul Robinson
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2014)
National Healthcare Safety Network (NHSN) report, data summary for 2012, Device-associated module
Margaret A. Dudeck et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2013)
Effect of Aerosolized Colistin as Adjunctive Treatment on the Outcomes of Microbiologically Documented Ventilator-Associated Pneumonia Caused by Colistin-Only Susceptible Gram-Negative Bacteria
Mario Tumbarello et al.
CHEST (2013)
Polymyxins: Wisdom Does Not Always Come With Age
Zahra Kassamali et al.
CLINICAL INFECTIOUS DISEASES (2013)
The importance of protecting the mechanical ventilator during colistin methanesulfonate nebulization
Francesco Mojoli et al.
INTENSIVE CARE MEDICINE (2013)
Aerosol therapy during mechanical ventilation: an international survey
Stephan Ehrmann et al.
INTENSIVE CARE MEDICINE (2013)
Colistin: Re-emergence of the 'forgotten' antimicrobial agent
A. K. Dhariwal et al.
JOURNAL OF POSTGRADUATE MEDICINE (2013)
Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies
Wilhelmina G. Melsen et al.
LANCET INFECTIOUS DISEASES (2013)
Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study
Antje Schuster et al.
THORAX (2013)
Adjunctive aerosolized colistin for multi-drug resistant gram-negative pneumonia in the critically ill: a retrospective study
Neha M. Doshi et al.
BMC ANESTHESIOLOGY (2013)
Fosfomycin/Tobramycin for Inhalation in Patients with Cystic Fibrosis with Pseudomonas Airway Infection
Bruce C. Trapnell et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Aerosolized Antibiotics for Ventilator-associated Pneumonia Lessons from Experimental Studies
Jean-Jacques Rouby et al.
ANESTHESIOLOGY (2012)
Efficacy of High-dose Nebulized Colistin in Ventilator-associated Pneumonia Caused by Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii
Qin Lu et al.
ANESTHESIOLOGY (2012)
What Is the Efficacy and Safety of Colistin for the Treatment of Ventilator-Associated Pneumonia? A Systematic Review and Meta-Regression
Diana F. Florescu et al.
CLINICAL INFECTIOUS DISEASES (2012)
Eradication of multidrug-resistant Acinetobacter baumannii from the respiratory tract with inhaled colistin methanesulfonate: a matched case-control study
S. -C. Kuo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
BAY41-6551 achieves bactericidal tracheal aspirate amikacin concentrations in mechanically ventilated patients with Gram-negative pneumonia
Michael S. Niederman et al.
INTENSIVE CARE MEDICINE (2012)
Pharmacokinetics of inhaled colistimethate sodium (CMS) in mechanically ventilated critically ill patients
Zoe E. Athanassa et al.
INTENSIVE CARE MEDICINE (2012)
Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens
Drosos E. Karageorgopoulos et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis
M. N. Hurley et al.
JOURNAL OF CYSTIC FIBROSIS (2012)
Use of high-dose IV and aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia: do we really need this treatment?
Gamze Kalin et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2012)
Use of Adjunctive Aerosolized Antimicrobial Therapy in the Treatment of Pseudomonas aeruginosa and Acinetobacter baumannii Ventilator-Associated Pneumonia
Heather M. Arnold et al.
RESPIRATORY CARE (2012)
Implications of endotracheal tube biofilm in ventilator-associated pneumonia response: a state of concept
Sara Gil-Perotin et al.
CRITICAL CARE (2012)
Nebulized Ceftazidime and Amikacin in Ventilator-associated Pneumonia Caused by Pseudomonas aeruginosa
Qin Lu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
A retrospective observational study on the efficacy of colistin by inhalation as compared to parenteral administration for the treatment of nosocomial pneumonia associated with multidrug-resistant Pseudomonas aeruginosa
Reinout Naesens et al.
BMC INFECTIOUS DISEASES (2011)
Incidence of and Risk Factors for Colistin-Associated Nephrotoxicity in a Large Academic Health System
Jason M. Pogue et al.
CLINICAL INFECTIOUS DISEASES (2011)
Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining Fluid Focus on Antibacterial Agents
Keith A. Rodvold et al.
CLINICAL PHARMACOKINETICS (2011)
What the pulmonary specialist should know about the new inhalation therapies
B. L. Laube et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Pharmacokinetics and Tolerability of Amikacin Administered as BAY41-6551 Aerosol in Mechanically Ventilated Patients with Gram-Negative Pneumonia and Acute Renal Failure
Charles-Edouard Luyt et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2011)
Pseudomonas aeruginosa antibiotic susceptibility during long-term use of aztreonam for inhalation solution (AZLI)
Christopher M. Oermann et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial
Michael W. Konstan et al.
JOURNAL OF CYSTIC FIBROSIS (2011)
Monotherapy with inhaled colistin for the treatment of patients with ventilator-associated tracheobronchitis due to polymyxin-only-susceptible Gram-negative bacteria
Z. E. Athanassa et al.
JOURNAL OF HOSPITAL INFECTION (2011)
Aerosol drug delivery: developments in device design and clinical use
Myrna B. Dolovich et al.
LANCET (2011)
Nebulized colistin treatment of multi-resistant Acinetobacter baumannii pulmonary infection in critical ill patients
M. J. Perez-Pedrero et al.
MEDICINA INTENSIVA (2011)
Use of colistin in treating multi-resistant Gram-negative organisms in a specialised burns unit
H. Ganapathy et al.
BURNS (2010)
Steady-State Pharmacokinetics and BAL Concentration of Colistin in Critically Ill Patients After IV Colistin Methanesulfonate Administration
Roberto Imberti et al.
CHEST (2010)
Aerosolized plus Intravenous Colistin versus Intravenous Colistin Alone for the Treatment of Ventilator-Associated Pneumonia: A Matched Case-Control Study
Diamantis P. Kofteridis et al.
CLINICAL INFECTIOUS DISEASES (2010)
Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study
I. P. Korbila et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa
Qin Lu et al.
INTENSIVE CARE MEDICINE (2010)
Application of a Droplet Evaporation Model to Aerodynamic Size Measurement of Drug Aerosols Generated by a Vibrating Mesh Nebulizer
Nagaraja Rao et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2010)
Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria
Pinyo Rattanaumpawan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Aerosolized Colistin for the Treatment of Multidrug-resistant Acinetobacter baumannii Pneumonia: Experience in a Tertiary Care Hospital in Northern Taiwan
Cheng-Chih Lin et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2010)
Consensus Summary of Aerosolized Antimicrobial Agents: Application of Guideline Criteria Insights from the Society of Infectious Diseases Pharmacists
Jennifer Le et al.
PHARMACOTHERAPY (2010)
Ventilation with lower tidal volumes as compared with conventional tidal volumes for patients without acute lung injury: a preventive randomized controlled trial
Rogier M. Determann et al.
CRITICAL CARE (2010)
Serum Concentrations of Aerosolized Tobramycin in Medical, Surgical, and Trauma Patients
Steven D. Burdette et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Helen W. Boucher et al.
CLINICAL INFECTIOUS DISEASES (2009)
Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance
D. E. Ghannam et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2009)
Nebulized ceftazidime in experimental pneumonia caused by partially resistant Pseudomonas aeruginosa
Fabio Ferrari et al.
INTENSIVE CARE MEDICINE (2009)
Tigecycline possibly underdosed for the treatment of pneumonia: a pharmacokinetic viewpoint
Olaf Burkhardt et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Adjunctive Aerosolized Antibiotics for Treatment of Ventilator-Associated Pneumonia
Quinn A. Czosnowski et al.
PHARMACOTHERAPY (2009)
Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia
Charles-Edouard Luyt et al.
CRITICAL CARE (2009)
Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients
Alexandre P. Zavascki et al.
CLINICAL INFECTIOUS DISEASES (2008)
Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit
Lucy B. Palmer et al.
CRITICAL CARE MEDICINE (2008)
Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: A multicenter, randomized study
Jean Chastre et al.
CRITICAL CARE MEDICINE (2008)
Aerosol delivery during mechanical ventilation: From basic techniques to new devices
Rajiv Dhand
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2008)
Guidelines for the management of hospital-acquired pneumonia in the UK: Report of the Working Party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy
R. G. Masterton et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: A prospective study
Argyris Michalopoulos et al.
RESPIRATORY MEDICINE (2008)
Administration of antimicrobials via the respiratory tract for the treatment of patients with nosocomial pneumonia: a meta-analysis
Eleni Ioannidou et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Compounded colistimethate as possible cause of fatal acute respiratory distress syndrome
Karen S. McCoy
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Salvage treatment of pneumonia and initial treatment of tracheobronchitis caused by multidrug-resistant Gram-negative bacilli with inhaled polymyxin B
Graziella H. Pereira et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
Mutant selection window hypothesis updated
Karl Drlica et al.
CLINICAL INFECTIOUS DISEASES (2007)
Pharmacokinetics of inhaled colistin in patients with cystic fibrosis
F Ratjen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Administration of antibiotics via the respiratory tract for the prevention of ICU-acquired pneumonia: a meta-analysis of comparative trials
Matthew E. Falagas et al.
CRITICAL CARE (2006)
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies
Matthew E. Falagas et al.
CRITICAL CARE (2006)
Appropriateness and delay to initiate therapy in ventilator-associated pneumonia
CM Luna et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Penetration of gentamicin into the alveolar lining fluid of critically ill patients with ventilator-associated pneumonia
D Panidis et al.
CHEST (2005)
Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa
ME Drobnic et al.
ANNALS OF PHARMACOTHERAPY (2005)
Disposition of instilled versus nebulized tobramycin and imipenem in ventilated intensive care unit (ICU) patients
JR Badia et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Use of inhaled ampicillin-sulbactam against multiresistant Acinetobacter baumannii in bronchial secretions of intensive care unit patients
M Horianopoulou et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Aerosol delivery and modern mechanical ventilation -: In vitro/in vivo evaluation
DD Miller et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Lung deposition and efficiency of nebulized amikacin during Escherichia coli pneumonia in ventilated piglets
I Goldstein et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Clinical implications of basic research: Biofilms, antimicrobial resistance, and airway infection
AS Prince
NEW ENGLAND JOURNAL OF MEDICINE (2002)
A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis
ME Hodson et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
Evaluation of bronchial constriction in children with cystic fibrosis after inhaling two different preparations of tobramycin
GA Alothman et al.
CHEST (2002)
Aerosolized ceftazidime for prevention of ventilator-associated pneumonia and drug effects on the proinflammatory response in critically ill trauma patients
GC Wood et al.
PHARMACOTHERAPY (2002)
Lung tissue concentrations of nebulized amikacin during mechanical ventilation in piglets with healthy lungs
I Goldstein et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: A prospective case-control study
N Bercault et al.
CRITICAL CARE MEDICINE (2001)
Bronchoconstriction following nebulised colistin in cystic fibrosis
S Cunningham et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2001)
The influence of lung deposition on clinical response
JN Pritchard
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG (2001)
Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment
DL MacLeod et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
分享论文
